About 3billion
3billion is a company based in Seoul (South Korea) founded in 2016.. 3billion has raised $25.69 million across 4 funding rounds from investors including Korean Development Bank, Shinhan Financial Group and Yuanda Financial Holdings. The company has 85 employees as of December 31, 2024. 3billion offers products and services including 3B-GENOME, 3B-EXOME, 3B-VARIANT, 3B-INTERPRETER, and GEBRA™. 3billion operates in a competitive market with competitors including MedGenome, Foundation Medicine, Burning Rock, Zhejiang Nuhui Health Technology and Blueprint Genetics, among others.
- Headquarter Seoul, South Korea
- Employees 85 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 3Billion, Inc.
-
Annual Revenue
$3.91 M (USD)111.41as on Dec 31, 2024
-
Net Profit
$-4.45 M (USD)-29.06as on Dec 31, 2024
-
EBITDA
$-4.18 M (USD)11.03as on Dec 31, 2024
-
Total Equity Funding
$25.69 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Korean Development Bank
& 11 more
-
Employee Count
85
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 3billion
3billion is a publicly listed company on the KRX with ticker symbol 394800 in South Korea, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of 3billion
3billion offers a comprehensive portfolio of products and services, including 3B-GENOME, 3B-EXOME, 3B-VARIANT, 3B-INTERPRETER, and GEBRA™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides genome sequencing for rare disease identification and analysis.
Offers exome sequencing to detect variants in rare diseases.
Analyzes genetic variants for disease diagnosis and research.
Interprets genetic data for clinical and research applications.
Facilitates sample preparation for genetic testing processes.
Unlock access to complete
Funding Insights of 3billion
3billion has successfully raised a total of $25.69M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(11 Jul 2018)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2026 | Amount | Series D - 3billion | Valuation |
investors |
GVA ,
Industrial Bank of Korea
|
| Mar, 2021 | Amount | Series C - 3billion | Valuation | Wells Investment , JW Asset Management |
|
| Oct, 2019 | Amount | Series B - 3billion | Valuation | Korea Development Bank Europe |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in 3billion
3billion has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Korean Development Bank, Shinhan Financial Group and Yuanda Financial Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services are offered in healthcare and cannabis sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by 3billion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - 3billion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
3Billion Comparisons
Competitors of 3billion
3billion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Burning Rock, Zhejiang Nuhui Health Technology and Blueprint Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
|
| domain | founded_year | HQ Location |
Provider of early cancer screening and testing services
|
|
| domain | founded_year | HQ Location |
Genetic diagnostics and clinical interpretation for hereditary diseases are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about 3billion
When was 3billion founded?
3billion was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is 3billion located?
3billion is headquartered in Seoul, South Korea.
Is 3billion a funded company?
3billion is a funded company, having raised a total of $25.69M across 4 funding rounds to date. The company's 1st funding round was a Series B of $10M, raised on Jul 11, 2018.
How many employees does 3billion have?
As of Dec 31, 2024, the latest employee count at 3billion is 85.
What is the annual revenue of 3billion?
Annual revenue of 3billion is $3.91M as on Dec 31, 2024.
What does 3billion do?
An AI-driven clinical diagnostic testing platform for rare genetic diseases is provided by 3billion, founded in 2016 in Seoul, South Korea. Next-generation sequencing combined with machine learning and deep learning algorithms is utilized to analyze whole patient genomes for disease-causing mutations. A single test capable of detecting over 4000 rare genetic disorders is being developed within the healthcare technology sector.
Who are the top competitors of 3billion?
3billion's top competitors include Foundation Medicine, MedGenome and Burning Rock.
What products or services does 3billion offer?
3billion offers 3B-GENOME, 3B-EXOME, 3B-VARIANT, 3B-INTERPRETER, and GEBRA™.
Is 3billion publicly traded?
Yes, 3billion is publicly traded on KRX under the ticker symbol 394800.
Who are 3billion's investors?
3billion has 12 investors. Key investors include Korean Development Bank, Shinhan Financial Group, Yuanda Financial Holdings, Wells Investment, and JW Asset Management.
What is 3billion's ticker symbol?
The ticker symbol of 3billion is 394800 on KRX.